NET PROFIT (x1000 DKK)
EMPLOYEES
NXbio Development AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
1,822
|
1,262
|
2,368 |
Earnings before taxes |
-30,800
|
-13,059
|
-21,232 |
EBITDA |
-95
|
-111
|
-31 |
Total assets |
86,594
|
135,824
|
120,405 |
Current assets |
86,527
|
135,757
|
120,332 |
Current liabilities |
87
|
41
|
27 |
Equity capital |
54,637
|
84,773
|
106,456 |
- share capital |
2,536
|
2,523
|
2,745 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.1%
|
62.4%
|
88.4% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-33.5%
|
-8.7%
|
-15.7% |
Current ratio |
99456.3%
|
331114.6%
|
445674.1% |
Return on equity (ROE) |
-56.4%
|
-15.4%
|
-19.9% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
|
2 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.